Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/23/2010CA2378113C Controlled electroporation and mass transfer across cell membranes
11/23/2010CA2373302C Conditioned cell culture medium compositions and methods of use
11/23/2010CA2343655C Interleukin 17-like receptor protein
11/23/2010CA2263823C Mammalian artificial chromosomes
11/23/2010CA2222140C Packaging systems for human recombinant adenovirus to be used in gene therapy
11/23/2010CA2209301C Redirection of cellular immunity by protein-tyrosine kinase chimeras
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/23/2010CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof
11/18/2010WO2010132857A1 Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds
11/18/2010WO2010132788A2 Assay for mutations in stem cells and their derivatives
11/18/2010WO2010132708A2 Modulation of terminase activity at telomeres and dna double-strand breaks
11/18/2010WO2010132687A1 Compositions and methods for modulating cell differentiation
11/18/2010WO2010132686A1 Methods of using immunoglobulin aggregates
11/18/2010WO2010132315A1 Enhanced hematopoietic stem cell engraftment
11/18/2010WO2010131917A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
11/18/2010WO2010131821A1 Recombinant protein of fibroblast growth factor having adhesive activity for stem cells and method for culturing stem cells using the same
11/18/2010WO2010131747A1 Virus-producing cell
11/18/2010WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/18/2010WO2010131315A1 Induced mesenchymal stem cell and process for production thereof
11/18/2010WO2010131116A2 Use of lipid conjugates in the treatment of diseases associated with vasculature
11/18/2010WO2010131048A1 Temperature-responsive co-polymers and uses thereof
11/18/2010WO2010130446A1 A method for producing test systems from donors suffering from adverse effects of medicaments and/or medical treatments, and uses of said systems
11/18/2010WO2010130305A1 Automated separation of tissue layers
11/18/2010WO2010130008A1 Methods for the collection and maturation of oocytes
11/18/2010WO2010129987A1 Novel receptor hetero-dimers/-oligomers
11/18/2010WO2010083842A3 Expression of neuropeptides in mammalian cells
11/18/2010WO2010081171A3 Laser mediated sectioning and transfer of cell colonies
11/18/2010WO2010080978A3 Pre-depletion of leukocytes in whole blood samples prior to the capture of whole blood sample components
11/18/2010WO2010080530A3 Plant cell culture for production of natural products with reduced glucosinolate contamination
11/18/2010WO2010078183A3 Method of generating regulatory t cells using cord blood and adult blood cd14+ monocyte cells
11/18/2010WO2010068939A3 Bioactive grafts and composites
11/18/2010WO2009073523A9 De-differentiation of human cells
11/18/2010US20100293671 Composition and Method for Prolonging the Shelf Life of Banana by Using Interfering RNA
11/18/2010US20100293670 polynucleotides and related polypeptides of the ZmARGOS (Auxin-Regulated Gene involved in Organ Size) gene family; increase in plant height, thicker stems, increased biomass, ear length, total kernel weight per ear, kernel numbers per ear, kernel size, and grain yield
11/18/2010US20100293668 Genetically modified plants with altered inflorescence
11/18/2010US20100293667 Environmental Stress-inducible Promoter and its Application in Crops
11/18/2010US20100293665 Plants With Increased Yield (KO NUE)
11/18/2010US20100293664 Control of plant gene expression
11/18/2010US20100293662 Novel plant homeodomain protein-encoding genes and their uses
11/18/2010US20100293660 Plants and seeds of hybrid corn variety ch458156
11/18/2010US20100293625 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
11/18/2010US20100293624 Elimination of n-glucolylneuraminic acid from animal products for human use
11/18/2010US20100293623 Rabbit nuclear cloning method and uses thereof
11/18/2010US20100293118 Methods and systems for predicting protein-ligand coupling specificities
11/18/2010US20100292461 Plant cells and plants which synthesize a starch with an increased final viscosity
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292444 Novel Prolactin Compounds
11/18/2010US20100292441 Antibodies that specifically bind to GMAD
11/18/2010US20100292312 Anti-dll4 antibodies and methods using same
11/18/2010US20100292310 Micro-rna scaffolds and non-naturally occurring micro-rnas
11/18/2010US20100292302 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
11/18/2010US20100292300 Compositions and methods for inhibiting or reversing fibrotic disorders
11/18/2010US20100292297 Micrornas That Regulate Muscle Cell Proliferation and Differentiation
11/18/2010US20100292269 Bir domain binding compounds
11/18/2010US20100292200 Methods for Modulating Apoptosis in Platelets
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292179 Target
11/18/2010US20100292171 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin
11/18/2010US20100292169 Methods and compositions for regulating hdac6 activity
11/18/2010US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES
11/18/2010US20100292165 Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation
11/18/2010US20100292161 Polypeptides and methods of use
11/18/2010US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/18/2010US20100292155 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
11/18/2010US20100292152 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/18/2010US20100292151 Use of human cytokine receptor
11/18/2010US20100292145 Methods of regulating apoptosis
11/18/2010US20100292142 Novel neurotrophic factors
11/18/2010US20100292130 Biological active proteins having increased in vivo and/or in vitro stability
11/18/2010US20100292129 Methods and Compositions for Enhancing Proteasome Activity
11/18/2010US20100292099 Targeting of rna with external guide sequences
11/18/2010US20100291683 Modified Antigen Presenting Cells and Methods of Use
11/18/2010US20100291682 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291679 Composition for collecting and preserving placental stem cells and methods of using the composition
11/18/2010US20100291678 Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses
11/18/2010US20100291677 Reducer of immunosuppression by tumor cell and antitumor agent using the same
11/18/2010US20100291676 Humanized anti-cd4 antibody with immunosuppressive properties
11/18/2010US20100291675 IgM-MEDIATED RECEPTOR CLUSTERING AND CELL MODULATION
11/18/2010US20100291674 Disposable bioreactor, kit for the same and method for its production
11/18/2010US20100291673 Alternative export pathways for vector expressed rna interference
11/18/2010US20100291672 Reagent for introduction of protein or gene
11/18/2010US20100291645 Xylose reductase mutants and uses thereof
11/18/2010US20100291631 Novel Beta-Galactoside-Alpha 2,3-Sialyltransferase, a Gene Encoding Thereof, and a Method for Producing Thereof
11/18/2010US20100291627 Method for production of antibody
11/18/2010US20100291626 Enhanced expression and stability regions
11/18/2010US20100291625 Regulation of translation of heterologously expressed genes
11/18/2010US20100291624 Compositions and methods for improved glycoprotein sialylation
11/18/2010US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/18/2010US20100291613 Method of Positioning an Organic, Biological and/or Medical Specimen
11/18/2010US20100291610 Regulating Stem Cells
11/18/2010US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/2010US20100291550 Methods and compositions for modulating hair growth
11/18/2010US20100291533 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
11/18/2010US20100291262 Lipolytic Enzyme Variants
11/18/2010US20100291234 Compositions and methods for treating inflammatory arthritis
11/18/2010US20100291233 Treatment of neurological disorders
11/18/2010US20100291219 Methods and compositions relating to progenitor cells
11/18/2010US20100291213 Composite non-woven fibrous webs having continuous particulate phase and methods of making and using the same
11/18/2010US20100291211 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 1827